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I. INTRODUCTION 
Real-time polymerase chain reaction (qPCR) assays, based on detection of 
fluorescence signal increase during amplification (Higuchi et al., 1992), have 
become a method widely used for genome detection of pathogens in the past years 
(Mackay, Arden, and Nitsche, 2002). Due to the combination of high sensitivity, a 
reduced risk of cross-contamination through the absence of post-amplification 
handling and the possibility of quantitative analysis (Belak and Thoren, 2001; 
Espy et al., 2006; Niesters, 2004), qPCR assays are an excellent tool in molecular 
diagnostics. The simultaneous detection of multiple target sequences within a 
single reaction, referred to as “multiplex PCR”, is permitted by uniquely labelled 
probes and the separate detection of the spectra of their individual dyes (Wittwer 
et al., 2001). Possible applications of multiplex assays include the 
co-amplification of internal controls, the detection of different pathogens related 
to a disease complex or wild-type and vaccine strains of a virus for instance. 
Bovine herpesvirus type 1 (BoHV-1) associated diseases are distributed globally. 
They are characterized by rhinotracheitis (IBR), pustular balanoposthitis (IBP) 
and vulvovaginitis (IPV), abortion, conjunctivitis and occasional encephalitis 
(Gibbs and Rweyemamu, 1977). After initial replication in either respiratory, 
prepuce or vagina mucosal epithelium, the virus can enter neural cells and 
establish a life-long latent infection in the sensory ganglia of the nervous system 
(Engels and Ackermann, 1996; Muylkens et al., 2007). The latent virus, 
representing a long-term reservoir in hosts, may be reactivated by diverse stimuli 
resulting in recurred disease and shedding of the virus (Jones, 2003; Pastoret et 
al., 1979; Thiry et al., 1987). Latency and re-activation are responsible for the 
maintenance of BoHV-1 within cattle herds as well as for the introduction into 
free holdings (Winkler, Doster, and Jones, 2000). 
Extensive control programs have been initiated in several European countries 
including Germany. Major components of these programs are the detection of 
outbreaks and the vaccination with BoHV-1 mutants with deleted glycoprotein E 
(gE) coding regions. These marker vaccine viruses allow the serological 
discrimination between vaccination and field infection. As the deletion of gE in 
vaccine strains does not abolish the ability to establish latent infection and 
reactivation in the host (Lemaire et al., 2001; Straub, 1996; van Engelenburg et 
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al., 1995a), it is important to monitor the spread and shedding of wild-type BHV-1 
and differentiate them from live marker vaccine viruses. 
To allow the rapid nucleic-acid-based detection of gE-positive wild-type strains 
and their differentiation from gE-negative vaccine viruses within a single reaction, 
a multiplex PCR assay was developed and validated. 
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II. LITERATURE REVIEW 
1. Polymerase chain reaction 
1.1. Basic principle 
Developed by Mullis, acknowledged with the Nobel Prize in chemistry 
(http://nobelprizes.com/nobel/chemistry/), polymerase chain reaction (PCR) has 
become one of the most widely used methods for the amplification and detection 
of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). 
Besides the DNA template, PCR reactions contain oligonucleotide primers, four 
deoxyribonucleotide triphosphates (dNTP), a buffer with magnesium ions and the 
DNA polymerase enzyme. The primers are two oligonucleotides that flank the 
DNA sequence to be amplified. They are complementary to the sense and 
antisense strands of the template, respectively.  Repetitive cycles of heating and 
cooling are carried out resulting in billion-fold amplification of the nucleic acid 
fragment between the primer binding sites by the DNA polymerase. Each cycle 
comprises a denaturation, an annealing and an elongation step (Kubista et al., 
2006; Mullis et al., 1986). Nested PCR assays consist of two consecutive 
amplification reactions, the first using two external primers, followed by a 
reaction containing two internal primers targeting sequences within the first 
amplicon.  
For analysis of RNA targets the initial conversion into complementary 
deoxyribonucleic acid (cDNA) by a RNA-dependent DNA polymerase, the 
reverse transcription (RT), is required (Bustin and Mueller, 2005).  
The obtained PCR products of defined length can be visualized by electrophoresis 
using ethidiumbromide-stained agarose gels and a size marker for comparison. 
1.2. Real-time polymerase chain reaction 
In the real-time format, the increase of PCR products is detected directly during 
amplification (Higuchi et al., 1992). The two general formats for amplicon 
detection comprise fluorescent dyes intercalating with double-stranded DNA 
(dsDNA) and fluorogenic probes allowing specific detection of target sequences.  
Once bound to dsDNA, intercalating dyes give a fluorescence signal measurable 
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by qPCR cyclers (Figure 1). The accumulating amount of dsDNA over the course 
of PCR causes an increase in fluorescence from cycle to cycle. Besides ethidium 
bromide (Higuchi et al., 1992; Higuchi et al., 1993) and SYBR Green I (Ririe, 
Rasmussen, and Wittwer, 1997; Zipper et al., 2004), the currently most widely 
used intercalating dye, a variety of dyes such as ResoLight, Eva-Green or 
SYTO-82 are applied to monitor the accumulation of dsDNA during PCR (Li et 
al., 2010a; Mao, Leung, and Xin, 2007; Tajiri-Utagawa et al., 2009). Despite 
differences in the efficiency and level of PCR inhibition (Gudnason et al., 2007), 
all these dyes intercalate with any dsDNA including non-specific PCR products 
and primer dimers. As the dissociation temperature of the PCR product depends 
on its GC/AT-ratio, nucleotide sequence and length, discrimination of specific 
from unspecific PCR products is permitted by melting curve analysis, which is the 
evaluation of dsDNA dissociation and associated decrease of fluorescence during 
heating (Helps et al., 2002; Ririe et al., 1997).  
 
 
 
 
 
 
 
 
Fig. 1:  Basic principle of intercalating fluorescent dyes. Showing negligible 
fluorescence when distributed unbound in reaction solution, dye molecules 
intercalate with emerging double-stranded DNA during annealing and 
elongation steps of qPCR resulting in an increasing fluorescence signal.  
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In contrast to intercalating dyes, the application of oligonucleotide probes labelled 
with a fluorophore permits a more specific detection of amplicon sequences. 
Common chemistries comprise hydrolysis probes, minor groove binder (MGB), 
locked nucleic acid (LNA), hybridisation probes and molecular beacons.  
Hydrolysis probes, designed to hybridize within the target sequence between the 
primers, are oligonucleotides labelled with a reporter fluorophore at their 5’ end 
and a quencher at their 3’ end (Figure 2A). When exposed to light of a specific 
wavelength that varies with the used fluorophore, absorption of energy promotes 
electrons in the fluorophore from their ground state to an excited state. With the 
quencher in close proximity, this energy is transmitted non-radiatively to the 
quencher, returning the dye to its ground state. The quencher in turn releases the 
energy as light of a higher wavelength or, in case of non-fluorescent black hole 
quencher, as heat (Bustin, 2002; May et al., 2005; Morrison, 2010). Due to the 
5' → 3' exonuclease activity of the DNA polymerase, the probe is degraded into 
smaller fragments during amplification (Holland et al., 1991). The reporter 
becomes separated from the quencher resulting in an increasing, measurable 
fluorescence signal of a wavelength specific to the used reporter dye (Gibson, 
Heid, and Williams, 1996).  
An identical mechanism is used by probes conjugated with MGB groups (Figure 
2B). Because of forming stable duplexes with single-stranded DNA, MGB groups 
allow the design of shorter probes for hybridization based assays (Kumar et al., 
1998; Kutyavin et al., 2000).  
The incorporation of LNA, a nucleic acid analogue with unequalled hybridization 
affinity towards complementary DNA and RNA (Karkare and Bhatnagar, 2006), 
into probes increases the melting temperature which enables the use of 
significantly shorter probes (Alonso, Amoros, and Cuesta, 2010; Costa et al., 
2004).  
Hybridisation probes use a pair of oligonucleotides complementary to distinct but 
closely spaced sequences, one of them labelled 3’-terminally with a donor 
fluorophore, the other at the 5’ end with an acceptor (Figure 2C). After excitation, 
the donor fluorophore passes energy to the nearby acceptor through Förster 
resonance energy transfer (FRET), evoking an increasing, detectable fluorescence 
signal from the latter (Cardullo et al., 1988).  
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Molecular beacons contain a hairpin loop structure terminally labelled with 
reporter and quencher (Figure 2D). Their close contact is causing the quenching 
(collisional quenching) and the energy is dissipated as heat (Bustin, 2002). When 
hybridizing to the target sequence, the probe undergoes a conformational change 
separating the reporter fluorophore from the quencher.     
 
A                                                                B 
        
      
 
 
 C                                                                D 
 
      
 
 
 
Fig. 2:  Behaviour of different probe types over the course of a qPCR reaction.    
A. Hydrolysis probe. B. Minor groove binder probe. C. Hybridisation 
probe. D. Molecular beacon. In each case the first image depicts the 
denaturation step, followed by the annealing and elongation steps.  
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In both cases, intercalating dyes and fluorogenic probes, the measurement of the 
fluorescence signal is performed through the transparent lid of the reaction vessel 
thereby avoiding post-PCR handling (Belak and Thoren, 2001). As a result, the 
risk of cross-contamination and the time required for the generation of results is 
reduced considerably compared to conventional PCR evaluated by agarose gel 
electrophoresis (Espy et al., 2006; Mackay, 2004; Niesters, 2004). In addition, the 
96-well plate format is common in real time machines, permitting a combination 
with timesaving automated nucleic acid extraction.  
The observed increase in fluorescence during qPCR is proportional to the increase 
in concentration of the accumulating product, thus dependent on the starting 
amount of the target sequence (Higuchi et al., 1993). The amplification cycle in 
which the fluorescence signal first exceeds the background, referred to as 
quantification cycle (Cq) (Bustin et al., 2009), is used for quantification of the 
target (Gibson et al., 1996). The amount of target sequences is quantified either 
absolutely or relatively (Mackay, 2004).  
Absolute quantification requires a standard curve, generated by plotting the 
Cq-value against the logarithm of the starting copy number, after analysing a 
serial dilution of a known sample, for example a plasmid containing the sequence 
of the entire amplicon or a synthetic single-stranded positive sense 
oligonucleotide. The copy number of the sequence of interest in the unknown 
sample is calculated from the linear regression of the standard curve (Arya et al., 
2005; Bustin, 2000).  
In relative quantification, also referred to as comparative threshold method, the 
ratio between a reference control and the amounts of target sequence, normalized 
to one or more co-amplified housekeeping genes, is determined without the need 
of standard curve generation. For example untreated samples or samples from the 
starting point in time-course studies are used as reference control. To obtain 
reliable results it is essential that the amplification efficiencies of housekeeping 
gene and target sequences are approximately equal (Arya et al., 2005; Bustin, 
2002). 
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1.3. Multiplex polymerase chain reaction 
The amplification of multiple templates using multiple primers within a single 
reaction is called multiplex PCR, an opportunity that is provided by conventional 
as well as qPCR. 
In conventional PCR assays, multiplexing is permitted by differences in base pair 
(bp) length of the amplicons generated by the diverse primer pairs. An adequate 
resolution of the subsequent visualization by gel electrophoresis is necessary for 
discrimination (Chamberlain et al., 1988).  
Differences in the melting point of the amplicons as well as oligonucleotide 
probes labelled with fluorophores that have unique emission spectra enable 
multiplexing in the qPCR format (Wittwer et al., 2001).  
As mentioned above, dyes like SYBR Green I intercalate with any dsDNA. 
Nevertheless, differentiation of PCR products is possible by melting curve 
analysis, were the fluorescence is measured continuously while the temperature is 
raised. The strands of dsDNA become separated at a specific temperature 
resulting in a sudden decrease of fluorescence to the background level 
(Figure 3A-B). This melting temperature (Tm), determined as the maximum of the 
negative first derivative of the melting curve (Kubista et al., 2006), depends on 
GC/AT ratio, length and nucleotide sequence of the dsDNA fragment. Primer 
dimers are distinguishable due to significant differences in length compared to 
specific products, resulting in a lower Tm (Ririe et al., 1997). Differences in Tm of 
reaction products up to 2°C are resolvable, a change of 1°C is expected with a 
variances of 2.4% in GC content for instance (Wittwer et al., 2001). In contrast to 
gel electrophoresis, qPCR using intercalating dyes and subsequent melting curve 
analyses enables the discrimination of sequences of equal length but different 
GC/AT ratio (Ririe et al., 1997).   
Contrary to differentiation by melting curves, colour multiplexing uses uniquely 
labelled probes (Figure 3C). A large number of fluorescent dyes are available 
currently; a selection of dyes used commonly and their optimal excitation and 
emission wavelengths is shown in Table 1. 
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 A                                                                  B 
 
 
 
 
 
 
 
       C 
 
 
 
 
 
 
 
 
 
 
Fig. 3:  Differentiation of two qPCR products in one reaction by melting 
temperature (A-B) and colour (C). A depicts the melting curves and B the 
negative first derivative of the melting curve. 
 
 
 
Dye Excitation maximum (nm) Emission maximum (nm)
Alexa Fluor 350 346 442
ResoLight 487 503
6-carboxy-Fluorescein (FAM) 492 518
SYBR Green 497 520
EvaGreen 503 527
Tetrachloro-6-carboxy-fluorescein (TET) 521 538
2,7-Dimethoxy-4,5-dichloro-6-carboxyfluorescein (JOE) 520 548
Yakima Yellow 530 549
Hexachloro-6-carboxy-fluorescein (HEX) 535 556
Carbocyanin 3 (Cy3) 550 570
6-carboxy-tetramethyl-rhodamine (TAMRA) 544 576
6-carboxy-X-Rhodamin (ROX) 575 602
Sulforhodamine-101-acid-chloride (Texas Red) 589 615
Carbocyanin 5 (Cy5) 635 665  
 
Table 1: Selection of fluorescent dyes used in qPCR. Dyes intercalating with  
   double-stranded DNA are printed in italics.  
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However, the spectra of individual dyes overlap thereby reducing the number of 
possible combinations. In multiplex assays dyes with excitation and emission 
wavelengths different enough to detect them separately have to be selected. 
Otherwise the increasing fluorescent signal in one detection channel can spread to 
a channel used to detect another dye, referred to as crosstalk, which results in a 
falsely positive result in the second channel (Gunson et al., 2008). Crosstalk is 
preventable by appropriate choice of dyes to be combined in a multiplex assay 
and proper PCR machine calibration including spectral compensation (Ishii, 
Sootome, and Yamashita, 2007; Wittwer et al., 2001). On the other hand, the 
number of detection channels in real-time PCR machines, currently four to five in 
most cases, limits the number of target sequences discriminable in a single 
reaction by colour multiplexing (Gunson, Collins, and Carman, 2006).            
Some wavelengths previously occupied by the emissions from the early quenchers 
themselves, have been made available by the development and application of 
non-fluorescent black hole quenchers (Mackay, 2004). 
Multiplex PCR and qPCR offer a variety of possible applications. A common 
implementation for duplex PCR, the amplification of two targets, is the 
co-amplification of an internal control (IC) along with a pathogen-specific target. 
The usage of ICs is essential to verify efficient extraction of nucleic acids and to 
ensure the absence of PCR-inhibiting factors, especially when investigating 
potentially difficult biological matrices (Belak and Thoren, 2001; Hoffmann et al., 
2009). Either heterologous internal controls, meaning nucleic acid of non-sample 
origin added to the sample during nucleic acid extraction (Hartman, Coyne, and 
Norwood, 2005; Hoffmann et al., 2005; Hoffmann et al., 2006; Niesters, 2004; 
Stranska et al., 2004), or ICs based on housekeeping genes are used. The latter are 
genes that are theoretically expressed steadily in different tissues and at all stages 
of development (Arya et al., 2005). Examples for housekeeping genes used in 
PCR diagnostics are beta-actin, a cytoskeletal structural protein, glyceraldehyde-
3-phosphate dehydrogenase, a glycolytic enzyme, ubiquitin C, involved in protein 
degradation, beta-2-microglobulin, the beta-chain of major histocompatibility 
complex class I molecules, or  hypoxanthine phosphoribosyl-transferase 1, an 
enzyme in purine nucleotide synthesis (Li et al., 2010b; Moniwa et al., 2007; 
Oleksiewicz, Donaldson, and Alexandersen, 2001; Toussaint et al., 2007; 
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Vandesompele et al., 2002; Wakeley et al., 2005). However, even housekeeping 
genes have variable messenger RNA (mRNA) concentrations, depending on the 
quality of the clinical sample.  
1.4. Optimization and validation 
Optimization, the process by which the most important parameters of an assay are 
evaluated and adjusted to ensure that the performance characteristics of the assay 
are best suited to the intended application, and validation, the process that 
determines the fitness of an assay for an intended purpose (OIE, 2011; OIE - 
World Organisation for Animal Health), are crucial in the development of PCR 
assays. Already difficult in the development of single-target approaches, both 
processes are a huge challenge in the design of multiplex assays. Every primer 
pair and probe included in a multiplex PCR has to be optimized for identical 
reaction conditions, including temperature, concentration of dNTPs, magnesium 
chloride and template nucleic acid.  
Major critical factors of influence are the sequence and concentration of primers. 
Designed to detect as many strains or types as possible of the target pathogen, 
false-positive results caused by closely related species have to be avoided. 
Initially optimized in a single-target reaction, unpredictable interactions such as 
reduced sensitivity or the formation of non-specific PCR products may occur 
when adding another primer pair (Gunson et al., 2008). The likelihood of 
obtaining non-specific products, primarily primer dimers, increases noticeably 
when using more than one primer pair per PCR reaction (Brownie et al., 1997). In 
addition, the preferential amplification of one of the targets in multiplex assays is 
a well known phenomenon (Mutter and Boynton, 1995; Polz and Cavanaugh, 
1998). As PCR reactions have a limited supply of enzyme and dNTPs for which 
all products compete, the target which is amplified more efficiently negatively 
influences the yield of further products (Henegariu et al., 1997; Markoulatos, 
Siafakas, and Moncany, 2002). Possible explanations for the bias towards one 
template are differences in the GC content, causing preferential denaturation, and 
secondary structures in the target, leading to varying accessibility of the target 
region within the genome (Elnifro et al., 2000). Differences in GC/AT ratio 
between the primers cause unequal binding efficiencies. Consequently, the GC 
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contents of the primers combined in one assay, as well as their lengths, have to be 
dovetailed to result in nearly identical annealing temperatures. To reduce the 
amplification bias, the application of a reduced concentration of primers specific 
for the more efficient target is useful (Henegariu et al., 1997; Markoulatos et al., 
2002). Additionally, the lower primer concentration reduces the likelihood of 
non-specific products. An increase of the length of primers, allowing higher 
annealing temperature, yields fewer non-specific products as well (Henegariu et 
al., 1997). In conclusion, the adjustment of the sequence and concentration of 
each primer specific for every target in the multiplex PCR is essential.   
Apart from primers, the amount of DNA polymerase is critical in multiplex PCR 
assays. The application of higher enzyme concentrations compared to 
single-target assays significantly improves the reliability of multiplex systems 
(Persson, Hamby, and Ugozzoli, 2005). On the other hand an unbalanced 
amplification of the targets and an increase in background is observed when using 
too much enzyme, possibly caused by the high glycerol concentration in the stock 
solution (Henegariu et al., 1997; Markoulatos et al., 2002).  
As the enzymatic activity of the DNA polymerase is magnesium-dependent an 
optimal amount within the reaction is required. Too much magnesium stabilizes 
dsDNA, preventing complete denaturation, and inadequately low concentrations 
result in a reduced quantity of the PCR product (Markoulatos et al., 2002). Due to 
magnesium binding, an excessive increase of dNTP concentrations inhibits PCR, 
however extremely low concentration results in a reduced amount of product. A 
balanced ratio between magnesium and dNTP is required (Henegariu et al., 1997). 
In general, variation in the concentration of each PCR component is greater in 
multiplex compared to single-target assays. However, the effects of individual 
PCR conditions have to be determined empirically (Gunson et al., 2006; Wittwer 
et al., 2001).  
After development and optimization, the subsequent validation of a diagnostic 
assay for infectious diseases includes an estimation of its performance, 
comprising analytical and diagnostic sensitivity and specificity, repeatability and 
reproducibility among others (OIE, 2011). 
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2. Bovine herpesvirus type 1 
2.1. Taxonomy and molecular characteristics 
Cattle can be infected by various members of the family Herpesviridae (Trapp, 
Beer, and Mettenleiter, 2003), which is divided into the subfamilies 
Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae  by the Inter-
national Committee on the Taxonomy of Viruses (Davison et al., 2009; Fauquet et 
al., 2005). Currently described herpesviruses are assigned to two subfamilies. 
BoHV-4 and BoHV-6 are regarded as Gammaherpesvirinae and BoHV-1, 
BoHV-2 and BoHV-5 as Alphaherpesvirinae. Characterized by a short 
reproductive cycle, rapid spread in culture, a wide host range and the ability to 
establish lifelong latency (Roizman et al., 1981; Roizmann et al., 1992), 
Alphaherpesvirinae are subdivided into the genera Itovirus, Mardivirus, 
Simplexvirus and Varicellovirus. Based on biological and genomic properties, 
BoHV-1, the prototype member of ruminant herpesviruses (Schwyzer and 
Ackermann, 1996), is classified as belonging to the genus Varicellovirus, together 
with equine herpesvirus 1 and 4 (EHV-1, EHV-4), suid herpesvirus 1 
(pseudorabies virus, SuHV-1) and the ruminant herpesviruses BoHV-5, bubaline 
herpesvirus (BuHV), cervine herpesvirus 1 and 2 (CvHV-1, -2) and caprine 
herpesvirus 1 (CapHV-1), among others. BoHV-2 is assigned to the genus 
Simplexvirus (Davison et al., 2009; Fauquet et al., 2005). 
Based on antigenetic properties and restriction enzyme digestion patterns, 
BoHV-1 isolates are classified into subtypes 1.1 and 1.2, the latter is further 
subdivided into BoHV-1.2a and BoHV-1.2b (Miller, Whetstone, and Van der 
Maaten, 1991). The former subtype 1.3, responsible for fatal meningoencephalitis 
in calves (Meyer et al., 2001), has been reclassified as distinct herpesvirus named 
BoHV-5 (Roizmann et al., 1992; Smith, Young, and Reed, 1995).  
BoHV-1 particles, like typical herpesvirus virions, are approximately 150 to 
200 nm in size and consist of four components, namely core, capsid, tegument and 
envelope (Roizman and Baines, 1991; Roizmann et al., 1992) (Figure 4). 
.   
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The core, associated with the linear dsDNA genome, is included in an icosahedral 
capsid constructed of 162 capsomeres. Core and capsid form the nucleocapsid, 
which is surrounded by a layer of proteinaceous material, referred to as tegument. 
The latter, in turn, is enclosed in the outer lipid bilayer membrane of the virion, 
the envelope, which contains viral glycoproteins (de Oliveira et al., 2008; 
Mettenleiter, 2002).  
The dsDNA genome of BoHV-1 is approximately 136,000 bp of size (Schwyzer 
and Ackermann, 1996) and contains a unique long (UL) and a unique short 
segment (US). The latter is flanked by two inverted repetitive sequences, referred 
to as internal repeat (IR) and terminal repeat (TR). This genome organisation 
corresponds to class D of herpesvirus genomes, in which the UL segment is 
predominantly arranged in one orientation, while the US region inverts its 
orientation relative to UL resulting in two isomeric forms of virion DNA in 
equimolar amounts (Muylkens et al., 2007; Pellett and Roizman, 2007; Roizman, 
1996; Wirth, Vogt, and Schwyzer, 1991) (Figure 5).  
The majority of the BoHV-1 genome consists of genes homologous to other 
alphaherpesviruses and genes are generally labelled in accordance with the related 
genes of the prototype herpes simplex virus 1 (Muylkens et al., 2007). The 
BoHV-1 genome, comprising a GC content of 71.5% (Meyer et al., 1997), codes 
for at least 70 proteins, among them a number of enzymes, a group of regulatory 
proteins, major and additional glycoproteins (Muylkens et al., 2007; Nandi et al., 
2009). 
 
 
 
Fig. 5:  Scheme of BoHV-1 genome, which is divided into a unique long segment 
(UL) and a unique short segment (US) flanked by internal (IR) and terminal 
(TR) inverted repeats. Arrows indicate inversion of the US region resulting 
in two equimolar isomeric forms. (Beer et al., 2010a, modified)   
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2.2. Glycoprotein E 
Based on the impact of its deletion on the ability to grow in cell culture, every 
BoHV-1 gene is classified as either essential or non-essential. The deletion of 
essential genes results in a lethal non-replicative mutant, while the absence of 
non-essential genes allows further, but possibly  stunted, growth in vitro 
(Muylkens et al., 2007). In BoHV-1, the glycoprotein E (gE = US8), located in the 
US region (Figure 2) and encoding a 575 amino acid (aa) polypeptide with a 
predicted molecular mass of 65 kiloDalton (Rebordosa et al., 1994), is known to 
be non-essential (Baranowski et al., 1996; Muylkens et al., 2006).  
Due to the involvement of gE in direct cell-to-cell spread, gE-deleted mutants can 
only spread to neighboring cells via the extracellular fluid. This mechanism is less 
efficient and results in formation of smaller plaques (Rebordosa et al., 1996). 
Correlated with this observation, gE-deleted BoHV-1 strains are significantly less 
virulent in cattle compared to the parental wild-type strains (Kaashoek et al., 
1998; van Engelenburg et al., 1994), due to a highly impaired neuronal spread. 
2.3. Pathogenesis, clinical disease, immunology 
The majority of herpesviruses is associated closely with a single host species 
(Davison, 2002), BoHV-1 predominantly infects cattle. Nevertheless, other 
species of domestic or wild ruminants, such as goat, sheep, buffalo, bison, red 
deer and reindeer can be infected by BoHV-1 as well (Kalman and Egyed, 2005; 
Sausker and Dyer, 2002; Scicluna et al., 2010; Thiry et al., 2006).  
Most commonly, BoHV-1 is transmitted directly by aerosol or by close contact 
between infected animals. The main sources of infection are nasal exudates, 
genital secretions, semen and foetal tissues. Indirect transmission by contaminated 
food or water may occur likewise (Beer, 2010a; Engels and Ackermann, 1996; 
Nandi et al., 2009). Portals of entry are the respiratory tract, the eyes and the 
genital tract.  
After an incubation period of 2–7 days, a variety of syndromes may be caused by 
BoHV-1, namely infectious bovine rhinotracheitis (IBR), infectious pustular 
vulvovaginitis (IPV) in cows and infectious balanoposthitis (IPB) in bulls, while a 
subclinical course may occur as well (Gibbs and Rweyemamu, 1977).  
IBR is characterized by acute inflammation of the upper respiratory tract resulting 
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in fever up to 42°C, inappetence, depression, dyspnoea, coughing, sneezing, 
hyperaemia of the nasal mucosa and nasal discharge, which is initially serous and 
later muco-purulent. The mucosal membranes of eyes, mouth, or genital tract may 
be affected as well. Usually, animals recover within 2 weeks. The morbidity may 
amount to 100%. The low mortality rate of 2-10% may be increased by secondary 
infections, either of viral or bacterial origin (Gibbs and Rweyemamu, 1977; Nandi 
et al., 2009; Turin, Russo, and Poli, 1999; Yates, 1982). 
Symptoms of the genital forms include fever, depression and painful urination. In 
cows, the vulva is swollen and hyperaemic with pustules and discharge. In bulls, 
the lesions on the mucosa of penis and prepuce are similar to those of IPV and 
may be associated with a decrease in semen quality. Usually, lesions resolve 
within two weeks in both cases, IPV and IBP (Turin et al., 1999).  
After emerging in cattle holdings that include pregnant cows, abortions may occur 
from 3 to 6 weeks post infection, mainly between the fifth and eight month of 
pregnancy (Muylkens et al., 2007; Nandi et al., 2009; Turin et al., 1999). 
Furthermore, BoHV-1 may cause conjunctivitis associated with profuse 
lacrimation and, extremely rarely, meningoencephalitis. In those cases, clinical 
signs in affected animals comprise ataxia from stumbling to falling, depression, 
tremor, opisthotonus and clonic spasms among others. Coma and death often 
occur within four days after the onset of neurological symptoms (Gibbs and 
Rweyemamu, 1977).    
Besides bovine viral diarrhoea virus and bovine parainfluenza virus 3, BoHV-1 is 
one of the pathogens involved in the multi-factorial bovine respiratory disease 
complex (BRDC), also referred to as shipping fever. The immunosuppression 
induced by BoHV-1 leads frequently to secondary bacterial infections with 
Pasteurella haemolytica, Pasteurella multocida and Haemophilus somnus for 
instance. These superinfections may even cause severe pneumonia with resulting 
casualties (Jones and Chowdhury, 2007).  
In the hosts, BoHV-1 infection induces a specific immune response mediated by 
B- and T-cells, as well as a non-specific response, which is mediated by 
macrophages, polymorphonuclear neutrophils, natural killer cells, interferon and 
complement (Campos et al., 1989; Denis et al., 1993). The humoral immunity is 
becoming detectable from 8 days after infection. Specific antibodies against the 
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glycoproteins B and D are measurable starting 8-14 days post infection, while 
gE-specific antibodies are detectable for the first time 14-35 days after infection. 
This discrepancy is attributed to the reduced immunogenicity of gE (Beer, 2010a; 
Beer et al., 2003). Colostrum-derived maternal antibodies persist up to 9, in rare 
cases up to 12, months. Although protecting against clinical disease, maternal 
antibodies may inhibit the specific antibody production after vaccination (Lemaire 
et al., 2000; Menanteau-Horta et al., 1985). Immunity to BoHV-1 protects against 
clinical disease, not from infection and virus replication and shedding. 
Elimination of the virus is not achieved, because vaccination can not prevent 
lifelong latency in the sensory ganglia (Ackermann and Engels, 2006; Babiuk, van 
Drunen Littel-van den Hurk, and Tikoo, 1996). 
2.4. Latency and reactivation 
According to other alphaherpesviruses, BoHV-1 establishes a lifelong latent 
infection subsequent to an acute infection (Muylkens et al., 2007; Pastoret and 
Thiry, 1985). Latency is defined as a period without successful virus detection by 
standard virus isolation procedures and may last for whole life of the host. The 
latency-reactivation cycle may be divided into the major steps establishment, 
maintenance, and reactivation (Jones, 2003). After initial replication in either 
respiratory, prepuce or vagina mucosal epithelium the virus can enter the axons of 
local nerve cells. By subsequent intra-axonal transport, the viruses reach the 
neuron bodies in the regional ganglia, where latency can be established (Engels 
and Ackermann, 1996). Viral genomic DNA can be detected in the sensory 
ganglia of the trigeminal nerve or, in case of IPV/IPB, in sacral spinal ganglia 
(Ackermann and Wyler, 1984; Nandi et al., 2009). Latency may also occur in 
tonsillar lymphoid cells and peripheral blood lymphocytes (Mweene, Okazaki, 
and Kida, 1996). During latency, viral antigens are not synthesized, only one viral 
transcript is known to be expressed abundantly, the latency-related RNA 
(LR RNA), which inhibits apoptosis in transiently transfected cells (Ciacci-
Zanella et al., 1999). 
The latent virus, representing a long-term reservoir in hosts, can be reactivated by 
several stimuli such as stress, parturition, transport, superinfection with other 
pathogens or immunosuppression by glucocorticoids (Msolla et al., 1983; Nandi 
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et al., 2009; Pastoret et al., 1979; Thiry et al., 1987). The reactivated virus is 
transported intra-axonally to the original portal of entry resulting in recurrent 
disease and the possible transmission to other susceptible hosts (Engels and 
Ackermann, 1996; Jones, 2003).  
2.5. Diagnosis 
Acute BoHV-1 infection may be suspected based on clinical and epidemiological 
findings. Nevertheless, a laboratory examination, using serological tests and/or 
virus detection, is required to reach a definite diagnosis (OIE, 2010). Serological 
tests include the virus neutralisation test and indirect or blocking enzyme-linked 
immunosorbent assays (ELISA). The various ELISAs permit the detection of 
antibodies in serum or plasma and, with lower sensitivity, in milk or bulk milk 
samples. During the acute phase of the infection virus may be isolated from nasal 
or genital swabs. In various cell cultures of bovine origin, the virus induces a 
cytopathic effect within 2–4 days. BoHV-1 is subsequently identified by 
neutralisation or antigen detection methods using monospecific antisera or 
monoclonal antibodies (OIE, 2010). Several conventional PCR assays have been 
developed for  the detection of viral genome sequences in clinical samples such as 
nasal swabs, semen, blood, ganglia and organ specimens including lung and 
lymph nodes (de Gee et al, 1996; Santurde et al., 1996; van Engelenburg et al., 
1993; van Engelenburg et al., 1995b; Wagter et al., 1996). Furthermore, an 
OIE-validated real-time PCR for BoHV-1 genome detection in extended bovine 
semen has been published (Wang et al., 2007). The diverse PCR assays enable the 
detection of BHV-1 prior to seroconversion. However, none of them, neither 
conventional nor real-time, enable the differentiation of vaccine strains and 
wild-type strains. 
2.6. Vaccination and control programs 
BoHV-1 is distributed globally; however, significant differences in regional 
incidence and prevalence were found (Ackermann and Engels, 2006; Straub, 
1991). Subtype 1 strains are present in Europe, North and South America. 
Subtype 2a has been isolated in Brazil and prior to the 1970s in Europe, while 2b 
strains are prevalent in Australia and Europe, but not Brazil (Edwards, White, and 
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Nixon, 1990; Jones and Chowdhury, 2007; Takiuchi et al., 2005; van Oirschot, 
1995).  
In several European countries control programs have been initiated with the aim 
of BoHV-1 elimination. As a result, the disease has been eradicated from Austria, 
Denmark, Finland, Sweden, Italy (Province of Bolzano), Switzerland, Norway 
and parts of Germany (Oberpfalz, Oberfranken, Unterfranken and Mittelfranken 
districts of Bavaria) according to OIE. Within the German control program, 
BoHV-1 infections are regulated by law since 1997 (Verordnung zum Schutz der 
Rinder vor einer Infektion mit dem Bovinen Herpesvirus Typ 1, BHV1-
Verordnung; geänderte Fassung vom 20.12.2005). Long-term objectives are the 
elimination of the disease and prevention of re-emergence in cattle holdings free 
of BoHV-1. However, the starting situation differed widely between the federal 
states, in Bavaria for example more than 80% of herds were free of BoHV-1, 
while in Brandenburg or Saxony-Anhalt the amount of cattle holdings positive for 
BoHV-1 exceeded 50% (Anonymous, 2001). Depending on the prevalence, the 
initiated control programs were either based on detection and culling of animals 
tested positive or on vaccination (Beer, 2010c). The former is used in regions with 
low prevalence, e.g. Bavaria; the latter in federal states in which BoHV-1 
infection is distributed widespread.     
Apart from safety and an efficacious induction of protective immunity, the 
possibility to differentiate animals infected naturally from vaccinated animals is 
an important feature of vaccines, especially in the context of areas free of BoHV-1 
and imposed trade restrictions in Europe (van Oirschot, 2001; Vannie et al., 
2007). Vaccine candidates with deletions of the non-essential glycoproteins gC, 
gE, gI and gG were evaluated, gC-deleted strains remained too virulent, while the 
immunogenicity of gI-null mutants was not adequate (Kaashoek et al., 1998; van 
Engelenburg et al., 1994). In analogy to the effective DIVA (differentiating 
infected form vaccinated animals) strategy for eradication of SuHV-1, gE-deleted 
strains were eventually selected for use as marker vaccines (Strube et al., 1996; 
van Oirschot et al., 1996). Exhibiting little residual virulence, the relevant 
immune response against BoHV-1 are induced by these vaccines strains, with the 
exception of gE-specific antibodies (Strube et al., 1996; van Engelenburg et al., 
1994). The vast majority of wild-type strains have shown to express gE (Rijsewijk 
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et al., 2000) and, as a consequence, induce a BoHV-1-specific immune reaction 
that includes antibodies against gE, which may be used for the serological 
differentiation of infected and vaccinated animals (Beer, 2010b). The DIVA 
strategy requires reliable test systems to identify vaccinated animals. In the case 
of BoHV-1, a gE-specific blocking-ELISA is widely used. The reduced sensitivity 
and specificity of the available gE-specific ELISA compared to the gB-specific 
ELISA (Beer et al., 2003; Geraghty et al., 2011; Kramps et al., 2004), is 
acceptable in early stages of vaccination-based control programs. In herds free of 
BoHV-1, a combination of serological tests may be necessary (Beer, 2010b; 
Vannie et al., 2007).  
As far as replicating virus is concerned, the detection of gE-deleted strains from 
live marker vaccines and their reliable distinction from wild-type strains with 
conventional methods is based on isolation in cell culture and subsequent 
immunofluorescence staining or restriction enzyme fragment length 
polymorphism analysis. For genome detection of gE-deleted BoHV-1 strains 
conventional PCR assay have been developed (Fuchs et al., 1999; Schynts et al., 
1999).  
Due to consequent implementation of marker vaccination, good progress in 
BoHV-1 eradication was achieved in several federal states. In Brandenburg or 
Saxony-Anhalt the share of cattle holdings free of wild-type virus now exceeds 
95% (Anonymous, 2011). 
However, the disadvantages of gE-deleted BoHV-1 vaccine strains have to be 
considered. They prevent the development of clinical signs and markedly reduce 
the shedding of virus after infection with a wild-type strain, but the infection itself 
is not avoided completely (OIE, 2010). In addition, the intranasal inoculation of 
live-attenuated vaccine strains can also lead to latent infection (Kalthoff et al., 
2010; Lemaire et al., 2001; van Engelenburg et al., 1995a). Furthermore, 
reactivation from latency and re-excretion of vaccine virus from the upper 
respiratory tract following experimental stimuli and in field conditions has been 
demonstrated (Dispas et al., 2003; Schynts et al., 2003; Straub, 1996). Hence, the 
monitoring of shedding and spread of wild-type BoHV-1 and the differentiation 
from live marker vaccine virus is an important measure within eradication 
programs. Furthermore, a reliable real-time PCR method is very useful e.g. in 
diagnostics of acute respiratory symptoms in cattle. 
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For the detection of recently applied or re-excreted gE-deleted BoHV-1 vaccine 
strains and the simultaneous detection and differentiation of wild-type strains no 
qPCR assay has been available. For this reason, a multiplex qPCR system, 
combining BoHV-1 gE- and gD-specific assays as well as an internal control 
based on the bovine beta-actin gene, was newly developed and fully validated 
following the OIE recommendations. 
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Abstract 
Two important components of control programs for Bovine herpesvirus type 1 
(BoHV-1), a major pathogen of cattle, are the detection of outbreaks and 
vaccination with glycoprotein E (gE)-deleted marker vaccines. In addition to 
serology, rapid and accurate investigation of BoHV-1 and genetic differentiation 
of vaccine and wild-type strains are also important methods. Therefore, a triplex 
quantitative real-time polymerase chain reaction (qPCR) for testing BoHV-1 was 
developed. Apart from a BoHV-1 specific glycoproteinD (gD) assay, a 
gE-specific system for differentiation between wild-type BoHV-1 and gE-deleted 
vaccine strains was established. Finally, an internal control, based on the 
beta-actin gene was introduced successfully completing the multiplex system. 
The triplex BoHV-1-qPCR has an analytical sensitivity of less than 10 genome 
copies per reaction, and the diagnostic sensitivity was equal to or even greater 
than that of the ‘gold standard’ method of virus isolation in cell culture. A series 
of reference strains, including gE-deleted BoHV-1 and field isolates were detected 
reliably. For validation of the specificity of the test, nasal swabs, semen and 
different organ material from cattle, negative for BoHV-1, and genetically related 
herpesvirus strains were examined. 
The new multiplex BoHV-1-specific qPCR system allows highly sensitive and 
rapid genetic detection and differentiation of BoHV-1 and will be a valuable 
method for the control of BoHV-1 infection. 
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1. Introduction 
Bovine herpesvirus 1 (BoHV-1), an Alphaherpesvirus, is a major pathogen of 
cattle causing a variety of syndromes such as Infectious Bovine Rhinotracheitis 
(IBR), Infectious Pustular Vulvovaginitis (IPV) in cows, and Infectious 
Balanoposthitis (IBP) in bulls (Gibbs and Rweyemamu, 1977). 
After acute infection, the virus can enter neural cells and establish a life-long 
latent infection in the sensory ganglia of the nervous system (Muylkens et al., 
2007). The latent virus can be reactivated by several stimuli such as stressful 
conditions (Thiry et al., 1987) or immunosuppression with glucocorticoids 
(Pastoret et al., 1979). The resumption of lytic BoHV-1 replication in animals 
infected latently is responsible for the maintenance of BoHV-1 within cattle herds 
and for the introduction of the infection into free holdings (Winkler et al., 2000). 
Control programs for BoHV-1 include vaccination with inactivated or modified 
live gE-deleted marker vaccines. These vaccines allow differentiation between 
cattle infected naturally and vaccinated cattle (van Oirschot et al., 1996) in 
analogy to the DIVA (differentiating infected from vaccinated animals) strategy 
for eradication of pseudorabies virus (SuHV) (Stegeman, 1995). Nevertheless, 
gE-deleted BoHV-1 strains are also shed, e.g. following intranasal inoculation, 
and can establish latent infections (Lemaire et al., 2001; van Engelenburg et al., 
1995a; Kalthoff et al., 2010). It has also been demonstrated that gE-negative 
vaccine viruses can be reactivated from latency and re-excreted from the upper 
respiratory tract (Straub, 1996). Therefore, it is important to develop methods for 
monitoring the shedding and spread of live marker vaccine viruses. Especially for 
diseased cattle or animals succumbed to the disease, a diagnostic instrument for 
rapid differentiation between injected recently or reactivated marker vaccine virus 
and infection with a BoHV-1 field virus is crucial for determination of the cause 
of the disease and for the implementation of protective measures against wild-type 
BoHV-1 infection. 
Various PCR assays for detection of BoHV-1 have been described (de Gee et al., 
1996; van Engelenburg et al., 1993, 1995b; Wagter et al., 1996). Compared to 
conventional PCR, real-time quantitative PCR assays (qPCR) have several 
advantages, such as a reduced risk of cross-contamination in the absence of    
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post-amplification handling of samples, semi-quantitative analysis, and 
simultaneous detection of several target sequences using multichannel analysis 
(Mackay, 2004; Mackay et al., 2002; Wittwer et al., 2001). An OIE-validated 
qPCR for detection of BoHV-1 glycoprotein B-specific sequences in extended 
bovine semen has been developed by Wang et al. (2007).  
The aim of this study was to develop a multiplex qPCR method for simultaneous 
detection of BoHV-1 gD- and gE-specific sequences combined with an internal 
control system. The new triplex BoHV-1 qPCR assay allows BoHV-1-specific 
detection and differentiation between wild-type BoHV-1 strains (gE-positive) and 
gE-negative vaccine viruses in clinical samples such as nasal swabs and bovine 
semen. In addition, an internal control (IC) based on the beta-actin gene was 
included to verify efficient DNA extraction and PCR amplification. 
 
2. Materials and methods 
 
2.1. Virus strains and samples for diagnosis 
 
A series of bovine herpesviruses including both BoHV-1.1 and BoHV-1.2 
reference strains, gE-deleted BoHV-1 vaccine virus strains, BoHV-1 field isolates, 
BoHV-2, BoHV-4 and BoHV-5 were used in this study. In addition, cervid 
(CvHV-1, CvHV-2), bubaline (BuHV-1), caprine (CapHV-1), equine (EHV-1), 
and porcine (SuHV-1) herpesviruses were tested. All strains were provided by the 
virus collection of the Friedrich-Loeffler-Institut, Insel Riems, Germany or kindly 
provided by Günther Keil (Friedrich-Loeffler-Institut, Insel Riems, Germany). 
BoHV-1 positive nasal swabs, serum, tissue samples and spiked negative semen 
were tested as well as samples from BoHV-1 negative cattle. 
 
2.2. Virus isolation 
 
Virus isolation was carried out using MDBK cells (Rie261, Collection of cell 
lines in veterinary medicine, CCLV, Friedrich-Loeffler-Institut, Insel Riems, 
Germany) according to the OIE manual (OIE, 2010). 
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2.3. DNA extraction 
 
DNA was extracted using the High Pure PCR Template Preparation Kit (Roche 
Diagnostics Deutschland, Mannheim, Germany) according to the manufacturer’s 
recommendations. Nasal swab samples were obtained from an animal experiment, 
where marker vaccinated and mock vaccinated animals were challenged with a 
BoHV 1.1 wild-type virus (Kalthoff et al., 2010). The animal experiment was 
reviewed and approved by the responsible State ethics committee. DNA was 
extracted with the NucleoSpin® 96 Virus Core Kit for automated extraction 
(Macherey-Nagel, Düren, Germany) and eluted in 100µl buffer finally. 
 
2.4. Primers, probes and qPCR 
 
For the selection of primers and probes, published sequences of BoHV-1 (NCBI 
database) were used and alignment-based primer and probe selection was 
supported by the software package Beacon Designer 2.06 (Premier Biosoft 
International, Palo Alto, CA, USA). The selected gD-sequences are highly 
conserved for BoHV-1, but to a lesser extent within the closely related ruminant 
alphaherpesviruses. The design of the gE-specific assay was optimized according 
to the respective gE-gene deletions in the different commercial BoHV-1 marker 
vaccines. The sequences of primers and probes are summarized in Table 1.  
 
Name Sequence 5 ’- 3’ Genome positiona Reference 
BHV1-gD5595-F CCGCCGTATTTTGAGGAGTCG 119658-119678 this study
BHV1-gD5704-R TCGGTCTCCCCTTCRTCCTC 119767-119748 
BHV1-gD-TEX Texas Red-TACGAGCCGCCGCCTGCCGC-BHQ2 119685-119704 
BHV1-gE3-883F CAATAACAGCGTAGACCTGGTC 122739-122760 this study 
BHV1-gE3-989R GCTGTAGTCCCAAGCTTCCAC         122844-122824 
BHV1-gE3-FAM FAM-TGCGGCCTCCGGGCTTTACGTCT-BHQ1 122778-122800 
bACT2-1030-F AGCGCAAGTACTCCGTGTG 2679-2697 Modified 
 ACT-1135-R CGGACTCATCGTACTCCTGCTT 2753-2774 Toussaint et al.(2007)
 ACT-1081-HEX HEX-TCGCTGTCCACCTTCCAGCAGATGT-BHQ1 2720-2744
gB-F (forward) TGTGGACCTAAACCTCACGGT 57499–57519 Wang et al. (2007) 
gB-R (reverse) GTAGTCGAGCAGACCCGTGTC 57595–57575 
Probe (BoHV-1) FAM-AGGACCGCGAGTTCTTGCCGC-TAMRA 57525–57545  
 
Table 1: Sequences of primers and probes used in the study. 
a BoHV-1: genome position according to Bovine herpesvirus type 1.1   
   complete genome (GenBank accession number AJ 004801). 
b ACT: genome position according to Bos taurus chromosome 25 
   (GenBank accession number NC 007326). 
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All oligonucleotides were synthesized by Metabion International (Planegg-
Martinsried, Germany). The primer ACT-1135-R and the probe ACT-1081-HEX 
for actin detection were used as described by Toussaint et al. (2007). The primer 
ACT2-1030F was designed with the Beacon Designer 2.06 software package 
using published sequence information of the bovine ACTB-gene. In contrast to 
the mRNA-specific forward primer by Toussaint, ACT2-1030F also amplifies 
genomic β-actin DNA. 
The triplex BoHV-1 qPCR was carried out using the Quanti-Tect Multiplex PCR 
NoROX Kit (Qiagen, Hilden, Germany). The triplex qPCR assay was optimized 
using a total reaction volume of 25 µl. For a single reaction, 1.5 µl RNase-free 
water, 12.5 µl 2× QuantiTect Multiplex PCR noRox Master Mix, 2 µl gD-specific 
Texas Red-labelled primer-probe-mix (10 pmol/µl BHV1-gD5595-F, 10 pmol/µl 
BHV1-gD5704-R, 1.25 pmol/µl BHV1-gD-TEX), 2 µl gE-specific FAM-labelled 
primer-probe-mix (10 pmol/µl BHV1-gE3-883F, 10 pmol/µl BHV1-gE3-989R, 
1.875 pmol/µl BHV1-gE3-FAM) and 2µl beta-actin-specific HEX-labelled 
primer-probe-mix (2.5 pmol/µl ACT2-1030-F, 2.5 pmol/µl ACT-1135-R, 
1.25 pmol/µl ACT-1081-HEX) were merged as master mix. Finally, 5 µl DNA 
template was added and qPCR was carried out using a Bio-Rad CFX 96 Real-
Time Detection System (Bio-Rad, Hercules, CA, USA). The following thermal 
profile was used: 
PCR initial activation step at 95 °C for 15 min; 42 cycles of three-step cycling 
consisting of denaturation at 95 °C for 1min, annealing at 58 °C for 30 s, and 
extension at 72 °C for 30 s. 
To compare the results with an established method, a BoHV-1 gB-specific qPCR 
was performed as described by Wang et al. (2007) using the identical DNA 
template. However, Wang et al. (2007) used DNA extracted by the Chelex 
method, therefore the qPCR has been modified regarding the extraction method. 
For a single reaction, 5.5 µl RNase-free water, 12.5 µl 2× Platinum Quantitative 
PCR SuperMix-UDG master mixture (Invitrogen, Carlsbad, CA, USA) and 2 µl 
gB-specific primer-probe-mix (4.5 pmol/µl of each primer, 3.0 pmol/µl probe) 
were pooled as master mix and 5 µl DNA template were added. 
All samples were tested as duplicates or triplicates, while all standard dilution 
series were tested in quadruplicates. Samples were considered positive when the 
Cq value was equal or less than 40. 
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2.5. Positive BoHV-1 standard DNA 
 
Supernatant of BoHV-1-infected cell culture was harvested and cleared by 
centrifugation (1500 x g, 4°C, 15 min). Subsequently the remaining supernatant 
was weighed and PEG6000 (Sigma, Germany) was filled up to 8% of the total 
weight. The solution was stirred at room temperature until PEG6000 was 
dissolved. Another stirring step at 4°C overnight was performed and after that the 
solution was cleared by centrifugation (3650 x g, 4°C, 30 min). Pelleted material 
was resuspended in an appropriate volume of NTE-buffer (150mM NaCl, 50mM 
Tris.HCl, 1mM EDTA). Purified DNA was extracted from this starting material 
by High Pure PCR Template Preparation Kit (Roche Diagnostics Deutschland, 
Mannheim, Germany), the concentration was determined by spectrophotometry, 
and the exact number of DNA molecules was calculated supported by an online 
program provided at http://www.molbiol.edu.ru/eng/scripts/01_07.html. 
 
2.6. Synthetic positive control DNA 
 
In order to generate quantifiable, stable and consistent standards, synthetic 
oligonucleotides were designed. To exclude potential cross-contaminations, the 
peak fluorescent signal for the positive control should be markedly lower than for 
positive samples. This was achieved by the artificial introduction of mismatches 
into the synthetic oligonucleotides. A variable number of mismatches in different 
positions of the probe-binding region were tested. 
 
3. Results 
 
3.1. Sensitivity 
 
The analytical sensitivity of the triplex BoHV-1 qPCR was determined using a 
series of 10-fold dilutions of the standard BoHV- 1.2-DNA. The assay amplified 
the DNA in a linear fashion from 106 copies down to 101 copies per reaction with 
an efficiency of more than 97% (Fig. 1).  
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Fig. 1: Analytical sensitivity of the BoHV-1 triplex assay based on 10-fold 
dilution series of the purified BoHV-1 strain “Schoenboeken” standard 
DNA. A regression curve was estimated by Bio-Rad CFX ManagerTM 
Software (Bio-Rad, Hercules, CA, USA). Samples were tested in 
quadruplicates. 
 
Comparison of the amplification efficiencies of the gE- and gD-target sequences 
revealed comparable quantification cycle (Cq; Bustin et al., 2009) values with 
only a marginal preference for the gE-amplification (Table 2). An identical 
analytical sensitivity was achieved using gD and gE plasmid standards (data not 
shown). The sensitivity of the new triplex-BoHV-1 qPCR was compared to virus 
isolation and the published gB-specific PCR (Wang et al., 2007). In addition, 
10-fold dilution series of BoHV-1 in cell culture medium and in extended semen 
were analysed by virus isolation, the gB-specific qPCR, and the triplex BoHV-1 
qPCR system. For all preparations, the sensitivity of the qPCR was equal to or 
greater compared to the ‘gold standard’ method of virus isolation. In addition, 
both PCR-systems, the gB-specific assay and the triplex BoHV-1 PCR, showed 
comparable results (Table 2). 
The diagnostic sensitivity was evaluated by testing different sample types 
including diagnostic submissions to the OIE and National Reference Laboratory 
for BoHV-1, Friedrich-Loeffler-Institut Insel Riems, Germany (cell culture 
material, nasal swabs; see Table 3), and nasal swabs obtained from an 
experimental BoHV-1 infection (Kalthoff et al., 2010). 
The nasal swabs from BoHV-1-infected calves showed comparable results when 
tested with the triplex BoHV-1 qPCR and the gB-specific assay by Wang et al. 
(2007). However, three very weak positive samples scored negative by the 
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gD-specific assay, whereas the gE-specific assay gave a positive result (Table 4). 
In one of these samples the gB-specific PCR showed a positive result. Infected 
calve 587 was negative by the gD-, gE- and gB-specific PCR on 7 dpi and again 
positive on 5 and 9 dpi, calve 605 gave a negative result on 5 dpi, but was positive 
on 3 and 7 dpi. 
 
gD gE β-Actin
  In medium 
10-2 2/2 2/2 24.59 23.92 27.66 24.91
10-3 2/2 2/2 27.74 27.01 30.15 28.00
10-4 2/2 2/2 31.03 30.10 32.43 31.16
10-5 2/2 2/2 34.32 33.21 33.61 34.75
10-6 2/2 2/2 38.11 36.99 34.34 37.39
10-7 0/2 0/2 >40 39.59 35.02 39.64
10-8 0/2 0/2 >40 >40 35.29 >40 
10-9 0/2 0/2 >40 >40 34.91 >40 
  In negative semen 
10-1 2/2 2/2 24.60 24.94 32.76 27.24
10-2 2/2 2/2 28.20 28.22 32.38 30.72
10-3 2/2 2/2 31.41 31.09 33.24 33.53
10-4 2/2 2/2 34.43 33.70 33.87 36.71
10-5 2/2 2/2 39.40 37.69 33.15 >40 
10-6 0/2 0/2 >40 >40 33.88 >40 
10-7 0/2 0/2 >40 >40 34.00 >40 
10-8 0/2 0/2 >40 >40 33.56 >40
  Dilution of BoHV 1
Virus isolation /positive
isolations/ number of replicates) Mean 
aCq of two extractions
Multiplex BoHV‑1 assay gB
 
 
Table 2: Sensitivity of the triplex BoHV-1 qPCR assay compared to virus  
    isolation or the BoHV 1-gB assay (Wang et al., 2007). 
    a Cq = quantification cycle. 
 
3.2. Specificity 
 
All BoHV-1 field virus strains tested were positive by the gD-specific PCR as 
well as by the gE-specific system with comparable Cq values, whereas all 
different gE-deleted vaccine strains scored negative by the gE-specific assay. The 
BoHV-1 strains were positive with similar Cq-values compared to the published 
gB-specific assay (Table 3). 
For validation of the diagnostic specificity of the BoHV-1 triplex qPCR assay, 41 
nasal swabs, 24 serum samples, 10 semen samples and 17 different tissue samples 
from BoHV-1 negative cattle were tested. All control samples were clearly 
negative by the gD-specific system as well as by the gE-specific assay with 
unequivocal positive results by the beta-actin PCR. 
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gD gE β-actin 
aCq Cq Cq Cq
BoHV‑1 Schoenboeken 998 25.33 24.05 31.88 24.46
Wangen 28.56 28.60 30.96 29.87
California 26.01 25.49 30.60 27.02
Würzburg 26.33 25.79 31.11 27.10
Calw 27.34 26.92 31.47 28.23
Schleswig Holstein 26.62 26.01 31.42 26.63
Intervet Lebendvacc 26.99 26.46 31.68 27.76
Lam 26.07 25.22 31.06 25.76
B30/01 27.10 26.41 31.18 27.34
RIAM (conventinal vaccine strain) 26.05 24.53 30.49 24.74
Cooper 27.55 26.74 32.35 27.65
2204 26.29 25.85 30.75 26.50
AUS12 27.83 25.83 30.49 26.18
Schoenboeken 27.89 26.91 30.88 27.66
RVB 008 SV 0990 27.07 25.99 29.24 27.01
RVB 091 33/81 II 28.07 27.57 32.22 28.31
V RVB 095 35097 27.77 27.10 31.28 28.25
RVB 097 Elö-Vakzinevirus 26.66 26.30 31.07 27.31
RVB x128 HW 2/80 27.07 26.38 30.41 27.10
RVB x129 IBR 9/87 30.01 29.44 33.89 30.41
RVB 191 TV5/84 28.59 28.06 32.84 28.90
RVB 366 Los Angeles 26.78 26.36 31.11 27.34
40F2 29.00 28.08 33.97 28.90
4393 27.68 27.15 31.95 28.09
11456 28.01 27.19 32.75 27.97
994 27.38 26.89 32.77 27.15
10295 29.56 29.03 32.71 29.37
10678 27.82 27.18 32.57 27.91
11850/1 27.39 26.91 32.83 27.03
3935 28.33 27.43 32.71 28.23
4073 28.48 27.52 33.32 28.19
SD 23/01 28.88 27.96 31.71 28.24
RD 1824 I 29.54 28.70 32.05 29.36
NB 441/01 I 27.28 26.72 32.35 27.09
RI 892/01 30.68 29.78 32.53 30.94
SD 8 28.09 27.46 32.53 28.03
ND 653 27.15 25.05 34.60 25.01
RI 1129/00 28.24 25.66 35.39 25.63
NB 394 25.94 24.51 33.64 24.00
BoHV‑1∆gE BAYOVAC® IBR-MARKER VIVUM, Bayer 26.71 >40 31.93 27.76
Bovilis® IBR, Intervet 22.77 >40 35.53 26.06
Rispoval® IBR-Marker vivum, Pfizer 16.98 >40 25.05 20.32
BoHV-2 >40 >40 30.61 >40 
BoHV-4 >40 >40 24.93 >40 
BoHV-5 >40 >40 31.41 25.07
BuHV-1 >40 26.75 29.97 23.48
CvHV-1 >40 33.67 33.02 25.74
CvHV-2 >40 33,12 29.80 25.32
CapHV-1 >40 >40 31.01 34.18
EHV-1 >40 >40 29.90 >40 
SuHV-1 >40 >40 28.13 >40 
Virus Strain/isolate Multiplex BoHV‑1 assay gB 
 
 
Table 3: Virus strains and isolates analysed by the triplex qPCR and by the  
    gB-specific assay designed by Wang et al. (2007). 
    a Cq = quantification cycle. 
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gD gE β-actin gB 
587 0 >40 >40 26.55 >40
1 31.65 31.06 28.99 32.14
3 25.34 25.25 27.57 25.92
5 22.90 23.07 25.66 24.16
7 >40 >40 26.20 >40
9 31.96 30.99 27.82 32.01
11 >40 >40 28.39 >40
13 >40 >40 27.58 >40
15 >40 >40 27.90 >40
590 0 >40 >40 28.33 >40
1 >40 >40 29.88 >40
3 26.84 26.78 29.17 27.73
5 27.25 27.10 28.22 28.09
7 >40 35.14b 30.41 >40
9 27.14 26.54 26.92 27.18
11 >40 >40 28.74 >40
13 >40 >40 30.45 >40
15 >40 >40 28.12 >40
600 0 >40 >40 22.32 >40
1 28.60 27.93 25.43 29.13
3 >40 34.20 27.31 35.47
5 33.94 33.71 28.13 35.00
7 >40 >40 23.88 >40
9 >40 >40 28.06 >40
11 >40 >40 29.92 >40
13 >40 >40 29.38 >40
15 >40 >40 30.39 >40
605 0 >40 >40 28.40 >40
1 29.24 28.95 28.86 29.72
3 35.36 33.91 31.00 34.45
5 >40 >40 31.01 >40
7 31.08 29.67 29.68 30.88
9 >40 >40 29.85 >40
11 >40 >40 30.17 >40
13 >40 >40 30.32 >40
15 >40 >40 29.79 >40
117 0 >40 >40 30.34 >40
1 30.09 29.47 30.03 30.77
3 25.05 25.35 27.57 26.06
5 24.77 24.70 27.52 25.70
7 22.88 22.63 25.55 23.52
9 27.08 26.37 27.58 29.04
11 32.47 31.45 30.22 32.82
13 >40 >40 29.76 >40
15 >40 >40 29.79 >40
220 0 >40 >40 31.77 >40
1 26.32 26.42 31.17 27.26
3 28.29 28.06 31.04 28.70
5 21.07 21.20 24.61 21.75
7 24.17 23.92 26.52 24.50
9 29.40 28.59 27.28 29.42
11 29.84 29.09 27.82 29.96
13 >40 35.57b 30.24 >40
15 >40 >40 31.17 >40
Animal dpi aCq values multiplex BoHV 1 assay
Vaccinated animals post infection with BoHV-1
Mock-vaccinated animals post infection with BoHV-1
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581 0 >40 >40 31.74 >40
1 26.13 26.23 29.31 27.15
3 25.07 25.00 28.62 25.43
5 23.88 23.86 26.97 24.77
7 23.19 22.96 25.53 23.63
9 29.11 29.11 28.52 29.91
11 35.69 33.78 29.27 35.55
13 >40 >40 29.61 >40
15 >40 >40 30.14 >40
593 0 >40 >40 30.05 >40
1 28.89 28.34 32.23 27.53
3 22.69 22.62 25.97 23.21
5 21.41 21.29 24.51 21.83
7 23.58 23.11 24.94 23.84
9 28.93 28.01 27.96 29.11
11 30.31 29.23 27.53 29.92
13 34.31 32.33 28.89 34.08
15 >40 >40 27.97 >40  
 
Table 4: Analyses of nasal swabs from calves infected with BoHV-1 by the triplex  
   qPCR and by the gB-specific assay described by Wang et al. (2007). 
    a Cq = quantification cycle. 
    b Only one of the duplicates scored positive. 
 
In addition, the triplex qPCR assay was carried out with DNA from a series of 
further herpesviruses, namely CvHV-1, CvHV-2, BuHV-1, CapHV-1, EHV-1 and 
SuHV-1, with a special emphasis on closely related ruminant alphaherpesviruses. 
All non-BoHV-1 herpesviruses were negative by the gD-specific qPCR and most 
of the non-BoHV-1 herpesviruses tested negative by the gE-specific assay. 
Interestingly, Bubaline herpesvirus 1 and Cervid herpesvirus 1 and 2 were 
positive with the gE-specific assay. However, in the published gB-specific assay 
BoHV-5, CapHV-1, BuHV-1, CvHV-1, and CvHV-2 were positive, 
demonstrating a much greater BoHV-1-specificity of the triplex qPCR. In 
addition, other common bovine viruses such as bovine viral diarrhea virus, bovine 
respiratory syncytial virus, parainfluenza virus and bluetongue virus were tested 
and both the gD- and gE-specific assay showed no nonspecific reactivity. 
 
3.3. Reproducibility and repeatability 
 
Intra-assay reproducibility of the new triplex qPCR was assessed with four 
replicates, of a 10-fold dilution series of standard BoHV-1.2 DNA. 
The inter-assay repeatability was determined with 10-fold dilution series on four 
separate days (Fig. 2). It was shown that 10 copies per reaction were detected 
reliably in the gD- as well as in the gE- specific assay. Mean values, standard 
deviations and coefficients of variation are shown in Fig. 2. 
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 a                                                                           
 
b 
 
Fig. 2:  Reproducibility and repeatability of the triplex BoHV-1 qPCR. The Cq 
values (y-axis) of 16 replicates of the BoHV-1 gD-assay (a) and of the 
BoHV-1 gE-assay (b) using a 10-fold dilution series of the BoHV-1 
“Schoenboeken” standard DNA (x-axis: log 10 initial quantity) are shown. 
Mean values are indicated alongside of each boxplot, standard deviations 
are depicted in parentheses and coefficients of variation in square brackets. 
Boxplots were designed by the R software (R Development Core Team, 
2009) 
III. Results 
 
37 
3.4. Synthetic positive Control 
 
In order to design a positive control differentiable from positive samples by a 
lower peak fluorescent signal, a variable number of mismatches in different 
positions of the probe-binding region were introduced into synthetic 
oligonucleotides (sequences are shown in Table 5). As shown in Fig. 3, the 
selected synthetic controls indeed allowed a differentiation of control DNA from 
natural BoHV-1 DNA due to the markedly lower fluorescence signals. 
 
 
Name Sequence 5’-3’  
  
oLPC12-BHV1-gD gaattcgaCCGCCGTATTTTGAGGAGTCGtacagc  
 TACGAGCCGCGGCCTGCCGG  
 gatgaGAGGATGAAGGGGAGACCGAatttcacg   
oLPC3-BHV1-gE   gaattcgaCAATAACAGCGTAGACCTGGTCtacagc  
 TGCGGCCTCCGCGCTTTAGGTCT 
  gatgaGTGGAAGCTTGGGACTACAGCatttcacg  
 
Table 5: Sequences of synthetic oligonucleotides used as positive controls. Oligo 
   binding regions are depicted in capitals, probe binding sites are  
   underlined. Mismatches in the probe region are highlighted in grey. 
 
 
3.5. Internal Control (IC) 
 
For validation of the IC-PCR, a comprehensive panel of tissue samples and body 
fluids such as nasal swabs, semen, and serum from BoHV-1 negative cattle were 
examined and all were positive by the β-actin specific qPCR assay (Table 5). In 
addition, reproducible unaltered positive reactions were obtained with all 
herpesvirus DNA preparations tested (Table 3) and gE- and gD- positive nasal 
swabs from BoHV-1 infected calves (Table 4). The amplification efficacy of the 
internal control-DNA was not affected by simultaneous co-amplification of 
BoHV-1 specific sequences. Reproducibility and repeatability were assessed with 
four replicates of cattle DNA extracted from blood on four separate days and the 
mean value was 33.08 with a standard deviation of 0.57. 
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a 
 
 
 
 
b 
 
 
 
 
Fig.3: Amplification plots of 10-fold dilution series of standard BoHV-1-DNA  
 and  BoHV-1 gD- (a) and BoHV-1 gE- (b) positive synthetic controls  
 tested with the triplex-BoHV-1 qPCR assay. 
III. Results 
 
39 
4. Discussion 
In this study, a triplex qPCR-assay for simultaneous detection of BoHV-1 gD- and 
gE-specific sequences was developed and validated. The new assay was designed 
to enable differentiation of BoHV-1 wild-type viruses and gE-deleted vaccine 
strains, in combination with an internal control based on the amplification of the 
bovine β-actin gene (Toussaint et al., 2007; Hoffmann et al., 2009a). 
Various conventional PCR assays have been described for the detection of 
BoHV-1 genomes in clinical samples such as bovine semen (van Engelenburg et 
al., 1993; Wagter et al., 1996), nasal swabs (de Gee et al., 1996), blood, ganglia 
(van Engelenburg et al., 1995a), and organ specimens such as lung and lymph 
nodes (Santurde et al., 1996). None of these assays, however, differentiate 
between infected animals and animals shedding an attenuated gE-deleted vaccine 
strain. A gE-specific conventional PCR-assay, which detects up to 3000 
molecules of viral genomes per reaction has been developed by Schynts et al. 
(1999). Nevertheless, BuHV-1, CapHV, CvHV-1 and -2 could be diagnosed 
falsely as BoHV-1 gE-negative strains by this PCR assay. 
 
Compared to conventional PCR, qPCR assays have several advantages, such as a 
reduced risk of cross-contamination based on the absence of post-amplification 
handling of samples and semiquantitative analysis. The possibility of 
simultaneous detection of several target sequences using multichannel analysis 
permits multiplex assays. These test systems can be used to detect different target 
sequences as well as for co-amplification of internal controls (Hoffmann et al., 
2009a, b, 2010). 
 
With the new assay, gD- and gE-specific sequences within the BoHV-1 genome 
can be detected, allowing differentiation between wild-type BoHV-1 and 
gE-deleted live vaccines simultaneously. As gE-deletion does not affect the ability 
of BoHV-1 to be shed or to establish a latent infection (Lemaire et al., 2001; van 
Engelenburg et al., 1995a; Straub, 1996), it is important to monitor the spread of 
gE-deleted vaccine viruses. Indeed, a gE-deleted virus was isolated from two 
cows in a field study (Dispas et al., 2003). In addition, the OIE and National 
Reference Laboratory for BHV1 of the Friedrich-Loeffler-Institut, Insel Riems, 
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Germany, received clinical samples which were positive for BoHV-1 repeatedly, 
which turned out to harbour gE-deleted marker vaccine virus. Reliable 
discrimination with conventional methods is associated with time consuming 
growth of the virus isolates in cell culture and subsequent immunofluorescence 
staining or restriction enzyme fragment length polymorphism (RFLP) analyses. In 
contrast, the new triplex qPCR enables rapid differentiation even without isolation 
in cell culture and contemporary implementation or relaxation of disease control 
measures. 
 
For detection of BoHV-1 in extended bovine semen, an important measure to 
ensure BoHV-1-free semen batches, an OIE-validated qPCR has been reported 
(Wang et al., 2007). Using the identical DNA template, the new triplex BoHV-1 
qPCR showed an equivalent performance compared to the mentioned gB-specific 
PCR. It has also been demonstrated that the new triplex PCR detects BoHV-1 in 
other material such as nasal swabs. 
 
An equal or even greater sensitivity was attained by the triplex qPCR in 
comparison to the reference method (virus isolation according to the OIE manual), 
demonstrating the equivalence of the time-saving qPCR approach. By testing 
dilution series of the standard DNA from BoHV-1.2 strain “Schoenboeken”, it 
was demonstrated that the new triplex system is a highly sensitive method for 
detection and differentiation of BoHV-1 genomes.  
A variety of different wild-type BoHV-1 strains was tested. All were found to be 
positive by the gD-specific PCR as well as by the gE-specific system, whereas all 
gE-deleted vaccine strains were negative by the gE-specific assay. The sensitivity 
of the gE-specific system was slightly greater compared to the gD assay, when 
testing diverse virus strains and the BoHV-1 dilution series, which reduces 
subsequently the likelihood of false results in an infected animal as a marker of 
vaccination. However, due to the marginal preference of the amplification of the 
gE-specific sequences by the triplex qPCR assay, the presence of BoHV-1 
genome in very weak gE-positive and gD-negative samples cannot be excluded. 
Testing nasal swabs collected from an animal experiment, samples of two 
individual calves were negative, while samples from the subsequent day were 
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positive. However, it should be noted that nasal swab material could show a 
greater variation since the amount of material is less standardised. 
BoHV-1 is closely related genetically and serologically to several ruminant 
alphaherpesviruses, namely BoHV-5, BuHV-1, CapHV-1, CvHV-1 and 2 (Ros 
and Belak, 1999, 2002; Thiry et al., 2006). BoHV-5 can cause fatal 
meningoencephalitis in calves (Meyer et al., 2001), and a PCR assay for 
differentiation of BoHV-1 and BoHV-5 has been developed by Claus et al. 
(2005). However, related non-BoHV-1 ruminant herpesviruses are able to cross 
the species barrier to infect cattle. Seroconversion was observed in cows infected 
with CapHV-1 (Engels et al., 1992) or with BuHV-1. Buffaloes can vice versa be 
infected successfully with BoHV-1 (Scicluna et al., 2010). The BoHV-1 genome 
has also been detected in goats, sheep and several deer species (Kalman and 
Egyed, 2005). Because of the high antigenetic and genetic relationship among 
these viruses, serological cross-reactivity occurs (Kramps et al., 2004; Lyaku et 
al., 1996) and false positive results by different PCR-assays were observed 
(Santurde et al., 1996; Schynts et al., 1999; Wang et al., 2007). In this way, 
BoHV-1-related ruminant herpesviruses may interfere with BoHV-1 eradication 
and control programs, and therefore BoHV-1-specific assays are also needed. 
Nucleotide homologies of parts of the highly conserved glycoprotein B gene from 
the five ruminant alphaherpesviruses, BoHV-1, BoHV-5, CapHV-1, CvHV 1 and 
CvHV 2, range between 87.2 and 99.6% (Ros and Belak, 1999). The phylogenetic 
analysis of the more variable gD-gene revealed homologies ranging between 71.3 
and 98.9%. As a consequence, all tested non-BoHV-1 herpesviruses were clearly 
negative by the BoHV-1 gD-specific qPCR in contrast to the gB-specific system. 
Only ElkHV-1 was not tested by the BoHV-1 triplex qPCR. However, due to the 
fact that the more closely related ruminant herpesviruses BoHV-5, CvHV-1 and -2 
were negative by the BoHV-1 gD qPCR, false positive results for ElkHV-1 were 
not expected. Furthermore, BuHV-1, CvHV-1 and CvHV-2 were positive by the 
BoHV-1 gE-specific assay, offering the possibility to detect infections with these 
viruses and differentiate them from BoHV-1 genome with a qPCR assay. 
 
In addition to the BoHV-1 gD- and gE-specific assays, an internal control (IC) 
PCR based on amplification of the bovine β-actin gene sequences was introduced. 
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To verify efficient DNA extraction and uninhibited amplification, heterologous 
internal controls (Hoffmann et al., 2005, 2006, 2009a) or IC based on 
housekeeping genes (Oleksiewicz et al., 2001) were used. The β-actin gene has 
been shown to be a suitable target for IC in several species (Oleksiewicz et al., 
2001; Wakeley et al., 2005). A large number of different tissue samples from 
BoHV-1 negative cattle were negative by the BoHV-1 gD- and gE-systems, 
whereas they were positive by the β-actin-specific qPCR in an equivalent 
quantity. Successful amplification of gD- and gE-specific sequences in samples 
from animals infected with BoHV-1 also did not interfere with amplification of 
the β-actin-IC. 
 
In conclusion, the new triplex qPCR is a sensitive and specific method for 
confirming the presence of BoHV-1 genome in field samples. In addition, this 
assay can differentiate between wild-type viruses and gE-deleted vaccine strains 
by a single qPCR reaction. 
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IV. DISCUSSION 
1. Multiplex polymerase chain reaction 
In this study, a three-colour multiplex qPCR based on hydrolysis probes was 
developed and validated. Owing to its diverse advantages, including the reduced 
risk of cross-contamination, a high sensitivity and the possibility of quantitative 
analysis, the real-time format was preferred to conventional PCR.  
The use of probes is associated with an increase in specificity compared to 
intercalating dyes like SYBR Green I. However, the choice of a genome region 
and probe sequence is challenging, since as many strains or types as possible of 
the target pathogen should be detected. The nucleotide mismatches between the 
probe and the target sequence, two in the case of the synthetic BoHV-1 positive 
controls, leads to a markedly lower florescence signal. Probes with incorporated 
LNA or MGB, which results in an increase in melting temperature and thereby a 
significant reduction of probe length, are even sensitive to single nucleotide 
mismatches, which is used in allele-specific assays for genotyping for instance 
(Alonso et al., 2010; Kutyavin et al., 2000). The effect of various primer and 
probe mismatches is complicated. Nevertheless, known consequences are the 
reduction of PCR efficiency with an increasing number of primer and/or probe 
mismatches, the even stronger effects of mismatches in both, primers and probe, 
on efficiency and the great effect of mismatches in the probe binding region  
(Smith, Vigilant, and Morin, 2002). It has been demonstrated that single point 
mutations in primer or probe binding regions in hydrolysis assays decrease PCR 
efficiency without fully abolishing the quantification, whereas mismatches of 
three or four nucleotides lead to complete inhibition of qPCR detection (Klein et 
al., 1999).  
In this study, the selected gD-sequences are highly conserved for BoHV-1, but to 
a lesser extent within the closely related alphaherpesviruses. As a result, the 
diverse tested BoHV-1 strains scored clearly positive in the gD-assay, whereas the 
closely related ruminant alphaherpesviruses were not picked up.  
Multiplexing, the combination of two or more assays in one reaction, offers a 
variety of advantages including savings in time, sample material and total costs. 
The development of multi-colour florescence-based PCR instruments allows 
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multiplexing by uniquely labelled probes. The spectra of the fluorescent dyes 
selected for probe labelling in this study are different enough to detect them 
separately. The described phenomenon of crosstalk in multiplex assays (Gunson 
et al., 2008) was not observed in any case.   
The critical optimization of multiplex assays was simplified in recent years by the 
provision of PCR reagents that are developed specifically for multiplex PCR, by 
some manufacturers. As an example, the ready-to-use master mix supplied by 
Qiagen, which has been used in this study, enables the reliable detection of up to 
five genomic DNA or cDNA targets in a single reaction (www.qiagen.com). 
However, minor differences observed in reagent lots of a SYBRGreen-based kit 
(Burgos et al., 2002) may also occur in other chemistries. For high amounts of 
template an adequate lot-to-lot reproducibility was observed, whereas the 
sensitivity varied for low copy numbers of the target (Burgos et al., 2002). 
Variation between different batches of primers and probes resulting in reduced 
PCR sensitivity have been described as well (Gunson et al., 2006). The 
comparative testing of new and old batches within the same PCR run using 
identical samples is recommended to avoid unnoticed lot-to-lot variations on 
sensitivity (Gunson et al., 2006).      
Another potential difficulty in multiplex reactions is the preferential amplification 
of one target (Mutter and Boynton, 1995; Polz and Cavanaugh, 1998). Therefore, 
in the PCR assay described in this study, a minimal concentration of the IC 
specific primers and probe was used in order to avoid competition with the 
pathogen-specific target. When analysing BoHV-1 genome, equal quantities of 
gE- and gD-specific sequences are expected. Consequently, a bias towards a 
higher concentrated target, which may be observed during the amplification of 
independent targets, is not expected in the BoHV-1 multiplex qPCR.  
Apart from the IC, the presence of several or even all significant pathogens in a 
specific disease complex, like respiratory, enteric, vesicular or reproductive, can 
be detected simultaneously with multiplex PCR. Diseases that are hard to 
distinguish by clinical signs are discernible in a single reaction. Thereby the 
quantity of required sample volume is reduced, which is especially important 
when sample material is rare (Persson et al., 2005). Furthermore, total testing 
costs and time are shortened (Gunson et al., 2008; Gunson et al., 2006). 
A multiplex qPCR for the detection and differentiation of the three major viruses 
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associated with the multi-factorial BRDC, namely BoHV-1, bovine viral 
diarrhoea virus and bovine parainfluenza virus 3, has been developed (Horwood 
and Mahony, 2011). The simultaneous detection of the pathogens potentially 
involved in an outbreak of bovine respiratory disease complex enables the 
appropriate treatment or management in a timely manner with minimal morbidity 
and mortality (Horwood and Mahony, 2011). To identify the causative agent of 
mucosal lesions in cattle, sheep and goats an assay for the detection of Rift Valley 
fever, bluetongue, rinderpest, and peste des petits ruminants viruses also described 
recently  (Yeh et al., 2011).  
For other animal species, multiplex PCR assays have been developed as well. As 
an example different viruses inducing reproductive and respiratory failure in 
swine, namely porcine circovirus type 2, classical swine fever virus, porcine 
parvovirus and porcine reproductive and respiratory syndrome virus, are 
discernible within a single reaction (Jiang et al., 2010). Classical and African 
swine fever are indistinguishable by either clinical or post-mortem examination 
(Kleiboeker, 2002), however multiplex PCR permits the fast genetic 
differentiation of the disease-causing virus (Aguero et al., 2004). The causative 
agent of indistinguishable vesicular lesions in epithelial tissues, be it 
foot-and-mouth disease virus, swine vesicular disease virus or vesicular stomatitis 
virus can be identified reliably in a timesaving multiplex approach (Fernandez et 
al., 2008). The rapid and specific diagnosis, especially after the unexpected 
re-emergence of a disease in free countries, is essential to prevent the spread into 
larger geographic areas affecting large animal populations (Belak, 2007).  
Furthermore, multiplex PCR is used to distinguish between viruses related 
genetically like BoHV-1 and 5 (Alegre, Nanni, and Fondevila, 2001; Claus et al., 
2005; Diallo, Corney, and Rodwell, 2011) or to differentiate genotypes of viruses 
like European and North American porcine reproductive and respiratory 
syndrome viruses (Egli et al., 2001; Kleiboeker et al., 2005).  
Another possible application for multiplex PCR assays is the genetic 
differentiation between vaccine and wild-type strains of a pathogen, used in the 
diagnosis of classical swine fever (Leifer et al., 2009) or EHV-1 infection 
(Osterrieder et al., 1994) for instance. This kind of differentiating on the basis of 
pathogen genomes is also called “genetic DIVA” (Beer et al., 2007) 
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2. Detection of Bovine herpesvirus type 1 genomes 
Control programs for BoHV-1 include vaccination with inactivated or attenuated 
gE-deleted marker vaccines. Although a number of BoHV-1-specific PCR assays, 
conventional as well as in real-time, have been described for different clinical 
samples, none of them enable the differentiation of vaccine strains and wild-type 
strains (de Gee et al., 1996; Santurde et al., 1996; van Engelenburg et al., 1993; 
van Engelenburg et al., 1995b; Wagter et al., 1996; Wang et al., 2007; Wiedmann 
et al., 1993). Considering the abundant nasal shedding of gE-deleted vaccine 
strains after intranasal application and their ability to establish latent infections 
with the possibility of reactivation and subsequent shedding, the monitoring of 
vaccine strains and their distinction from wild-type strains are important features 
in BoHV-1 diagnostics.  
In vaccination trials significant titres of live gE-negative vaccine strains were 
shown to be excreted after intranasal, but not after intramuscular application 
(Mars, de Jong, and van Oirschot, 2000; Strube et al., 1996). Since any excreted 
live virus could in principle infect other individuals, transmission experiments 
have been performed by Mars and colleagues (2000) to evaluate the average 
number of contact infections per infected individual. Although high amounts of 
BoHV-1 were observed in the nasal fluids of vaccinated animals, the gE-negative 
virus was transmitted to only one out of 15 co-housed sentinel cattle. It has been 
concluded that perpetuation of vaccine strains within cattle population is highly 
unlikely (Mars et al., 2000). Nevertheless, cases of gE-negative strains in clinical 
samples occur sporadically. In a field study, gE-deleted virus was isolated from 
two cows (Dispas et al., 2003). Therefore, it is important to monitor the spread of 
vaccine virus and to enable a rapid differentiation between vaccine virus 
replication and introduction of BoHV-1 wild-type virus into cattle holdings.  
To detect gE-deleted strains a conventional PCR assay has been described (Fuchs 
et al., 1999; Schynts et al., 1999). Noting the disadvantages of post-amplification 
handling, in this study a qPCR assay specific for gE-deleted BoHV-1 strains was 
developed, standardized and subsequently combined with an assay specific for 
BoHV-1 gD and an IC based on the bovine beta-actin gene (Toussaint et al., 
2007). In the gD-specific qPCR system wild-type as well as vaccine strains are 
picked up. As a consequence, samples positive in both BoHV-1 assays contain a 
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wild-type strain, whereas gE-deleted vaccine strains score positive in the 
gD-specific assay only. The IC-specific qPCR assay, included to verify efficient 
DNA extraction and uninhibited amplification, should give a positive result in 
case of both wild-type and vaccine strains as well as in samples containing 
neither.  
The control programs initiated in several European counties see only Bovinae as 
crucial in maintenance and spreading of BoHV-1. However, further species of 
domestic and wild ruminants may be also infected. BoHV-1 genome has been 
detected in goats, sheep, buffaloes, bison and several deer species (Kalman and 
Egyed, 2005; Sausker and Dyer, 2002; Scicluna et al., 2010; Thiry et al., 2006). 
Seropositive animals of other species could be considered as potential reservoir, 
though the epidemiological impact is still unknown (Kalman and Egyed, 2005; 
Scicluna et al., 2010). Cattle in turn may be infected with related non-BoHV-1 
ruminant herpesviruses (Engels et al., 1992). These genetically and serologically 
closely related pathogens include bubaline (BuHV-1), caprine (CapHV-1) and 
cervid (CvHV-1, CvHV-2) herpesviruses (Ros and Belak, 1999; Ros and Belak, 
2002). A closely related bovine herpesvirus possibly interfering with BoHV-1 
diagnosis is BoHV-5, formerly classified as BoHV-1 subtype 1.3. BoHV-5, which 
has never been reported in Germany (Beer, 2010a), can cause fatal 
meningoencephalitis in calves (Meyer et al., 2001). Several multiplex PCR assays, 
conventional (Alegre et al., 2001; Claus et al., 2005) as well as in real-time format 
(Diallo et al., 2011), for the differentiation of both bovine herpesviruses have been 
developed.   
The close genetic and serological relationship between ruminant herpesviruses 
and their ability to cross species barriers may interfere with diagnostics resulting 
in false-positive results. Indeed, significant serological cross-reactivity was 
observed, caprine and cervine herpesvirus 1 were shown to be more closely 
related to BoHV-1 than they are to each other (Lyaku, Nettleton, and Marsden, 
1992). False-positive results were likewise obtained in different PCR assays 
(Santurde et al., 1996; Wang et al., 2007), using the gE-specific conventional PCR 
described by Schynts et al. (1999). BuHV-1, CapHV-1, CvHV-1 and CvHV-2 
may be falsely classified as gE-deleted BoHV-1 strains. Within the gE-specific 
assay included in the multiplex qPCR of this study, BuHV-1, CvHV-1 and -2 
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were likewise tested positive. However, none of the tested non-BoHV-1 ruminant 
herpesviruses gave positive results in the gD-specific assay. In addition to the 
differentiation of wild-type and vaccine BoHV-1 strains, the newly developed 
multiplex qPCR offers the possibility to detect infections with the ruminant 
herpesviruses BuHV-1, CvHV-1 and 2 and simultaneously distinguish them from 
BoHV-1. The negative results in the gD-specific assay for the related viruses that 
the OIE-validated gB-specific assay described by Wang (2007) had picked up 
(BoHV-5, BuHV-1, CvHV-1, -2 and CapHV-1) may be explained by the different 
sequence homology of the gB and gD genes. Nucleotide homology between both 
BoHV-1 subtypes and non-BoHV-1 viruses is greater in the highly conserved 
gB-gene than within the gD-gene (Figure 6).  
 
 
gB
1 2 3 4 5 6
1 99.6 95.5 94.4 87.4 70.0 1 BoHV 1.1
2 100.0 95.9 94.9 87.2 70.4 2 BoHV 1.2
3 98.1 98.1 96.6 88.2 71.9 3 BoHV-5
4 94.8 94.8 95.5 87.8 71.7 4 CvHV-1
5 89.0 89.0 89.0 88.4 72.7 5 CapHV-1
6 69.7 69.7 69.0 68.4 70.0 6 SuHV-1
1 2 3 4 5 6  
 
 
gD
1 2 3 4 5 6
1 98.9 90.7 88.8 72.1 53.1 1 BoHV 1.1
2 97.8 90.3 88.6 71.3 52.9 2 BoHV 1.2
3 90.5 88.8 91.1 73.9 53.5 3 BoHV-5
4 86.6 86.0 84.4 76.2 56.7 4 CvHV-1
5 68.7 68.2 68.7 71.5 51.0 5 CapHV-1
6 40.7 40.1 40.1 43.5 38.4 6 SuHV-1
1 2 3 4 5 6  
 
 
Fig. 6:  Nucleotide and amino acid sequence similarities (%) for the gB and gD 
regions of ruminant Alphaherpesvirinae, SuHV-1 was used as the 
outgroup. (Ros et al. 1999, modified) 
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BoHV-2 and -4 are not assigned to the genus Varicellovirus within family 
Alphaherpesvirinae, but in genus Simplexvirus and the family Gamma-
herpesvirinae, respectively (Davison et al., 2009; Fauquet et al., 2005). Both 
viruses were tested negative by BoHV-1 gD-, gE- as well as gB-specific PCR 
which is due to the more distant relationship of these viruses.  
The diagnostic sensitivity and specificity was evaluated by testing different 
sample types, including cell culture supernatant, serum, nasal swabs and bovine 
semen. The main routes of excretion during primary infection are nasal exudates 
and genital secretions. After possible reactivation the virus is once again 
transported to the original portal of entry (Engels and Ackermann, 1996; Jones, 
2003). Consequently, the most important diagnostic samples are nasal swabs and 
semen. In addition, virus isolation as well as viral genome detection are important 
to verify the absence of BoHV-1 in extended bovine semen intended for 
international trade (OIE, 2010). When investigating serial 10-fold dilutions of 
BoHV-1 in extended semen, the sensitivity of the qPCR was equivalent to that of 
the “gold standard” method virus isolation in cell culture.  
Taking the saving of time and effort into consideration, qPCR is a suitable 
alternative to virus isolation, especially when screening semen samples prior to 
artificial insemination. Because a single ejaculate is diluted and inseminated into 
many females, semen should be screened for BoHV-1 to prevent virus 
transmission (Grom et al., 2006). BoHV-1 has been detected in semen of healthy, 
sero-negative bulls by virus isolation as well as by PCR (Deka et al., 2005; 
Kupferschmied et al., 1986; Rocha et al., 1998). Consequently, a serological 
negative status does not eliminate the risk of virus transmission through semen 
(Deka et al., 2005). However, in latently infected animals BoHV-1 diagnosis is 
limited to serological methods. During latency, defined as a period without virus 
detectable by standard virus isolation procedures, viral genome is not detectable 
by PCR in common diagnostic samples such as serum, nasal swabs or semen. 
Nevertheless, for diseased animals or animals shedding the virus without showing 
clinical signs, the newly developed qPCR is a rapid, sensitive and reliable tool to 
identify the disease-causing agent. 
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3. Concluding remarks 
Real-time polymerase chain reaction assays are widely used for genome detection 
of pathogens. Probes labelled with unique dyes in combination with the separate 
detection of their individual emission spectra in appropriate qPCR machines 
permits multiplex assays, which have recently been developed for several 
applications. Often internal controls were co-amplified in duplex assays. The main 
advantages of the amplification of multiple targets per reaction include a reduction 
of the required sample material, required time and total testing costs. The 
availability of ready-to-use reagents developed especially for multiplex assays has 
simplified the optimization of multi-target PCR systems and may lead to a further 
intensification of multiplexing.  
In this study, a three-colour multiplex qPCR assay for the detection and 
differentiation of BoHV-1 wild-type and gE-negative vaccine strains in a single 
reaction was developed and validated. In addition, it could be demonstrated that 
the ruminant herpesviruses BuHV-1, CvHV-1 and -2, which may infect cattle and 
interfere with control programs, are detected and distinguished from BoHV-1 by 
the multiplex qPCR. Especially for diseased animals, the newly developed 
multiplex qPCR is therefore a valuable diagnostic instrument for rapid, sensitive 
and reliable differentiation between recently acquired or reactivated gE-negative 
vaccine virus and infection with BoHV-1 wild-type strains. Furthermore, the 
qPCR may be used to monitor the spread of vaccine virus in cattle population, 
which has been reported sporadically, during screening tests for wild-type 
BoHV-1 without any additional expenditure. 
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V. SUMMARY 
Bovine herpesvirus type 1 (BoHV-1), an alphaherpesvirus, is a major pathogen of 
cattle causing different syndromes such as infectious bovine rhinotracheitis (IBR), 
infectious pustular vulvovaginitis (IPV) and infectious balanoposthitis (IBP). 
BoHV-1 control programs have been initiated in several European countries 
including Germany. One of the major components is the vaccination with 
inactivated or attenuated glycoprotein E (gE)-deleted live marker vaccines.  
The aim of this study was the development of a triplex real-time polymerase chain 
reaction (qPCR) assay for the sensitive, specific and reliable BoHV-1 detection. A 
BoHV-1-specific glycoprotein D (gD) assay was combined with a gE-specific 
qPCR system for differentiation between wild-type strains and gE-negative 
vaccine virus strains. Finally, an internal control based on amplification of the 
bovine beta-actin gene was introduced to verify efficient DNA extraction and 
PCR amplification.  
The analytical sensitivity of the triplex BoHV-1 qPCR enables the detection of 10 
genome copies per reaction. Furthermore, the sensitivity of the newly developed 
qPCR assay was compared to an OIE-validated qPCR and the “gold standard” 
method of virus isolation in cell culture using 10-fold dilution series of BoHV-1 
in extended semen as well as in cell culture medium. For all preparations, the 
tested qPCR assays showed comparable results and the sensitivity of the triplex 
qPCR was equal or even greater than that of virus isolation. A broad spectrum of 
reference strains and field isolates was detected reliably. The specificity of the test 
was confirmed using nasal swabs, semen and different organ materials of 
BoHV-1-negative cattle.  
Bovine herpesviruses type 2, 4 and 5 and further ruminant herpesviruses, namely 
bubaline herpesvirus (BuHV-1), caprine herpesvirus type 1 and cervine 
herpesvirus type 1 and 2 (CvHV-1, -2) were tested as well. The close genetic and 
serological relationship between these viruses combined with their ability to infect 
bovines may interfere with diagnostics resulting in false-positive results. All 
non-BoHV-1 herpesviruses were negative in the gD-specific assay, while 
BuHV-1, CvHV-1 and -2 were tested positive by the gE-specific qPCR. 
Consequently, the triplex qPCR offers for the first time the possibility to detect 
some related herpesviruses and distinguish them from BoHV-1 in addition to the 
simultaneous differentiation of BoHV-1 wild-type and gE-deleted vaccine strains. 
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VI. ZUSAMMENFASSUNG 
Das Bovine Herpesvirus vom Typ 1 (BoHV-1), ein Alphaherpesvirus, verursacht 
die wirtschaftlich bedeutenden Krankheitsbilder der infektiösen bovinen 
Rhinotracheitis (IBR), infektiösen pustulären Vulvovaginitis (IPV) und 
infektiösen Balanoposthitis (IBP). Umfassende Bekämpfungsprogramme wurden 
in mehreren europäischen Ländern, so auch in Deutschland, gestartet. Ein 
wichtiger Bestandteil dieser Programme ist die Vakzinierung mit inaktivierten 
oder attenuierten Glykoprotein E (gE)-deletierten Markerimpfstoffen.  
Ziel dieser Arbeit war es, eine Triplex Real-Time Polymerase-Kettenreaktion 
(qPCR) zum BoHV-1 Genomnachweis zu entwickeln. Ein Glykoprotein D (gD) 
spezifischer Assay wurde mit einem zweiten, gE-spezifischen qPCR System 
kombiniert, was die Differenzierung zwischen Stämmen vom Wildtyp und 
gE-deletierten Impfstoffen ermöglichte. Als Extraktions- und 
Amplifikationskontrolle wurde zudem der Nachweis von bovinem beta-Aktin 
integriert.  
Die analytische Sensitivität der Triplex BoHV-1 qPCR beträgt 10 Genomkopien 
pro Reaktion. Weiterhin wurde die Sensitivität der neuen Triplex-PCR mit der 
einer OIE-validierten qPCR und der „Goldstandard-Methode“ Virusisolierung in 
Zellkultur verglichen. Es wurden Verdünnungsreihen in Sperma und 
Zellkulturmedium untersucht, wobei beide qPCR-Systeme vergleichbare 
Ergebnisse erzielten und die neu entwickelte Triplex BoHV-1 qPCR eine der 
Virusisolierung mindestens gleichwertige Sensitivität zeigte. Eine Vielzahl von 
Referenzstämmen und Feldisolaten wurde zuverlässig erkannt. Die Spezifität 
wurde anhand von Nasentupfern, Sperma und verschiedenen Organmaterialien 
BoHV-1-negativer Rinder getestet.  
Weiterhin wurden die Bovinen Herpesviren vom Typ 2, 4 und 5, sowie die dem 
BoHV-1 nah verwandten Herpesviren der Büffelartigen (BuHV-1), Ziegen 
(CapHV-1), Hirsche und Rentiere (CvHV-1, -2), die auch bei Rindern eine 
Infektion hervorrufen können, getestet. Die enge genetische und antigenetische 
Verwandtschaft kann zu einer Beeinflussung der BoHV-1-Diagnostik in Form 
von falsch-positiven Ergebnissen führen. Sämtliche nicht-BoHV-1 Herpesviren 
wurden in der gD-spezifischen qPCR korrekt als negativ bewertet, während  
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BuHV-1, CvHV-1 and -2 positive Ergebnisse im gE-spezifischen Assay lieferten. 
Damit ermöglicht die Triplex qPCR, zusätzlich zur Unterscheidung von 
BoHV-1-Stämmen vom Wildtyp und gE-deletierten Impfviren, die zeitgleiche 
Detektion einiger nah verwandter Herpesviren und deren Differenzierung von 
BoHV-1. 
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VIII. ABBREVIATIONS 
aa  Amino acids 
bp  Base pair  
BoHV  Bovine herpesvirus 
BuHV  Bubaline herpesvirus 
BRDC  Bovine respiratory disease complex 
CapHV Caprine herpesvirus  
cDNA  Complementary desoxyribonucleic acid 
Cq  Quantification cycle 
CvHV  Cervid herpesvirus 
DIVA  Differentiating infected from vaccinated animals 
dNTP  Deoxyribonucleotide triphosphates 
(ds)DNA (Double-stranded) deoxyribonucleic acid 
EHV  Equine herpesvirus 
ELISA  Enzyme-linked immunosorbent assay 
FRET  Förster resonance energy transfer 
gE  Glycoprotein E, designations of glycoproteins appear with the 
prefix “g” 
IC  Internal control 
IBR  Infectious bovine rhinotracheitis 
IPB  Infectious balanoposthitis 
IPV  Infectious pustular vulvovaginitis 
IR  Internal repeat 
LR RNA Latency-related RNA 
LNA  Locked nucleic acid 
MGB  Minor groove binder 
OIE  World Organisation for Animal Health 
(m)RNA  (Messenger) Ribonucleic acid  
(RT)-PCR (Reverse transcription) Polymerase chain reaction 
(RT)-qPCR Real-time (reverse transcription) polymerase chain reaction 
SuHV  Suid herpesvirus 
Tm  Melting temperature 
TR  Terminal repeat 
UL  Unique long 
US  Unique short  
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